Browsing Category
Pharma Industry News
4724 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
GMP psilocybin manufacturing supports growing psychedelic clinical pipeline
Psyence Biomedical Ltd. exports GMP psilocybin for a Phase IIb cancer trial. Discover what this means for psychedelic medicine and biotech investors.
Servier bets $2.5bn on pediatric cancer specialist Day One Biopharmaceuticals (Nasdaq: DAWN)
Servier is acquiring Day One Biopharmaceuticals for $2.5B to expand its rare oncology pipeline. Discover what the deal means for pediatric cancer drug innovation.
How Persevere Therapeutics plans to reposition misetionamide in a crowded ovarian cancer pipeline
Persevere Therapeutics launches misetionamide ovarian cancer trial. Discover how its strategy could reshape treatment competition.
Could GraftAssureDx reshape access to transplant rejection monitoring? (Nasdaq: IMDX)
Could GraftAssureDx decentralize transplant rejection monitoring? Learn what Insight Molecular Diagnostics Inc.’s FDA push means for transplant diagnostics.
Could a proenzyme therapy disrupt chemotherapy’s dominance in pancreatic cancer treatment?
Can Propanc Biopharma’s PRP therapy reshape pancreatic cancer treatment? Discover what the biotech’s metastasis-focused strategy could mean for oncology.
Zevra Therapeutics appoints new CFO. Is the rare disease biotech entering its next commercial cycle?
Zevra Therapeutics appoints Justin Renz as CFO as the rare disease biotech prepares for commercialization expansion. Read what the leadership move signals.
The new engine of drug discovery? Inside Thermo Fisher Scientific’s cryo-EM hub in the Bay Area
Thermo Fisher Scientific opens a cryo-EM drug discovery center in South San Francisco to accelerate structural biology research. Discover why this matters for pharma.
Drug Farm advances DF-003 into FDA rare disease evidence pathway as ROSAH syndrome program enters regulatory dialogue phase
Drug Farm’s DF-003 enters the FDA Rare Disease Evidence Principles Process for ROSAH syndrome. Discover why this regulatory collaboration could shape rare disease drug development.
Does host-pathway targeting offer a durable COVID-19 strategy for Bioxytran, Inc.?
Bioxytran, Inc. reports early ProLectin-M data. Explore what host-targeted antivirals mean for COVID-19 strategy and biotech investors.
Does Priority Review signal a commercial breakthrough for Protagonist Therapeutics, Inc.?
Takeda and Protagonist secure FDA Priority Review for rusfertide in PV. Explore the strategic, financial, and competitive implications now.